Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market

Rhea-AI Summary

Modular Medical (NASDAQ:MODD) priced a public offering of 68,098,000 common shares (or pre-funded warrants) and warrants to purchase up to 68,098,000 shares at a combined public offering price of $0.1762 per share and warrant.

The warrants are exercisable immediately, expire five years from issuance, and the offering is expected to generate approximately $12.0 million in gross proceeds before fees. Closing is expected on or about March 4, 2026, subject to customary closing conditions.

Positive

• Gross proceeds of approximately $12.0 million
• Warrants exercisable immediately with five-year term
• Sole placement agent: Maxim Group LLC

Negative

• Offering of 68,098,000 shares plus warrants may dilute shareholders
• Shares and warrants priced at $0.1762 could pressure market price

Market Reaction – MODD

+4.52% $0.18 15.4x vol

15m delay 19 alerts

+4.52% Since News

$0.18 Last Price

$0.12 $0.18 Day Range

+$564K Valuation Impact

$13M Market Cap

15.4x Rel. Volume

Following this news, MODD has gained 4.52%, reflecting a moderate positive market reaction. Our momentum scanner has triggered 19 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $0.18. This price movement has added approximately $564K to the company's valuation. Trading volume is exceptionally heavy at 15.4x the average, suggesting very strong buying interest.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.

Key Figures

Shares offered: 68,098,000 shares Accompanying warrants: 68,098,000 warrants Offering price: $0.1762 per unit +3 more

6 metrics

Shares offered 68,098,000 shares Common stock (or pre-funded warrants) in public offering

Accompanying warrants 68,098,000 warrants Warrants to purchase common stock issued with offering

Offering price $0.1762 per unit Combined price per share (or pre-funded warrant) plus warrant

Warrant exercise price $0.1762 per share Exercise price for warrants issued in offering

Gross proceeds $12.0 million Expected gross proceeds before fees and expenses

Warrant term 5 years Warrants exercisable immediately and expiring five years from issuance

Market Reality Check

Price: $0.1570 Vol: Volume 5,108,983 is 8.32x...

high vol

$0.1570 Last Close

Volume Volume 5,108,983 is 8.32x above 20-day average of 614,192 shares. high

Technical Price $0.157 trades below 200-day MA at $0.61, reflecting a prolonged downtrend.

Peers on Argus

MODD was down 36.46% while only one peer (NMTC) showed momentum, rising 13.94%, ...

1 Up

MODD was down 36.46% while only one peer (NMTC) showed momentum, rising 13.94%, and broader peers were mixed, indicating a stock-specific reaction to the financing.

Previous Offering Reports

5 past events · Latest: Dec 10 (Negative)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 10	Equity offering pricing	Negative	-30.5%	Underwritten public offering of shares and warrants for about <b>$4.68M</b>.
Dec 09	Proposed equity offering	Negative	-30.5%	Announcement of proposed underwritten stock and warrant offering under Form S-3.
Sep 29	Warrant exercise financing	Negative	-0.6%	Reduced-price warrant exercises raising about <b>$4.4M</b> and issuing new warrants.
Nov 21	Equity offering pricing	Negative	-13.4%	Underwritten common stock offering at <b>$1.50</b> to raise roughly <b>$8.2M</b>.
Nov 21	Proposed equity offering	Negative	-13.4%	Launch of underwritten common stock and pre-funded warrant offering under S-3.

Pattern Detected

Equity offerings have consistently coincided with negative next-day moves, averaging -17.67%, suggesting a recurring dilution overhang.

Recent Company History

Over the past 18 months, Modular Medical has repeatedly tapped equity markets via public offerings and warrant-related financings, raising amounts like $8.2M, $4.68M, and $4.4M in gross proceeds. These events, all tagged as offerings, were generally followed by share price declines. The current $12.0M public offering continues this pattern of raising capital to fund Pivot insulin pump development and operations, reinforcing a history of shareholder dilution tied to ongoing funding needs.

Historical Comparison

-17.7% avg move · Past offering-related headlines for MODD averaged a -17.67% next-day move, showing that equity raise...

offering

-17.7%

Average Historical Move offering

Past offering-related headlines for MODD averaged a -17.67% next-day move, showing that equity raises have typically pressured the stock, so another financing fit that established pattern.

Series of equity and warrant financings used to fund Pivot insulin pump development and operations.

Market Pulse Summary

This announcement details a $12.0M best-efforts public offering of shares, pre-funded warrants, and ...

Analysis

This announcement details a $12.0M best-efforts public offering of shares, pre-funded warrants, and five-year warrants at $0.1762, expanding both share count and derivative overhang. It follows a series of prior offerings and warrant-related financings used to fund Pivot insulin pump development. Investors may weigh the immediate liquidity benefit against cumulative dilution, while also monitoring FDA timelines, Nasdaq bid-price compliance, and future capital needs signaled in recent S-1 and 10-Q disclosures.

Key Terms

pre-funded warrants, warrants, public offering, registration statement on form s-1, +2 more

6 terms

pre-funded warrants financial

"shares of its common stock (or pre-funded warrants in lieu thereof) and warrants"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

warrants financial

"and warrants to purchase up to an aggregate of 68,098,000 shares of its common stock"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

public offering financial

"today announced the pricing of a public offering with new and existing investors"

A public offering is when a company sells shares to the general public through the stock market, either by issuing new shares to raise cash or by letting existing owners sell their stakes. Think of it like a business opening its doors to many new owners at once: it can bring in money for growth but also increases the number of shares available, which can change the stock price and dilute existing ownership — key factors investors watch closely.

registration statement on form s-1 regulatory

"offered pursuant to a registration statement on Form S-1, (File No. 333-293842)"

A registration statement on Form S-1 is a detailed filing a company submits to the U.S. securities regulator to register new shares for public sale; it includes a plain-language prospectus, financial statements, business description and risk factors. For investors it matters because it provides the official, comprehensive blueprint of the offering — like an owner’s manual — allowing buyers to assess risks, inspect financial health and compare valuation before deciding to invest.

prospectus regulatory

"The offering is being made only by means of a prospectus which forms a part"

A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.

placement agent financial

"Maxim Group LLC is acting as the sole placement agent for the offering."

A placement agent is a professional or firm that helps organizations raise money from investors, such as individuals, institutions, or funds. They act like matchmakers, connecting those seeking investments with the right investors and guiding the process to ensure successful funding. For investors, they can provide access to exclusive opportunities and help navigate complex fundraising efforts.

AI-generated analysis. Not financial advice.

SAN DIEGO, CA / ACCESS Newswire / March 3, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced the pricing of a public offering with new and existing investors of 68,098,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 68,098,000 shares of its common stock at a combined public offering price of $0.1762 per share (or pre-funded warrant) and accompanying warrant. The warrants will have an exercise price of $0.1762 per share, will be exercisable immediately, and will expire five years from the date of issuance. The gross proceeds from the offering, before deducting placement agent fees and other offering expenses, are expected to be approximately $12.0 million. The closing of the offering is expected to occur on or about March 4, 2026, subject to the satisfaction of customary closing conditions.

Maxim Group LLC is acting as the sole placement agent for the offering.

The securities described above are being offered pursuant to a registration statement on Form S-1, (File No. 333-293842), which was declared effective by the Securities and Exchange Commission (the "SEC") on March 3, 2026. The offering is being made only by means of a prospectus which forms a part of the effective registration statement. A preliminary prospectus relating to the offering has been filed with the SEC. Electronic copies of the final prospectus, when available, may be obtained on the SEC's website at www.sec.gov and may also be obtained by contacting Maxim Group LLC at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Prospectus Department, or by telephone at (212) 895-3745 or by email at syndicate@maximgrp.com.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Modular Medical, Inc:

Modular Medical, Inc. (Nasdaq:MODD) is a medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."

Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.

Forward-Looking Statements

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statements contained in this press release, including the expected gross proceeds from the offering, and the timing and completion of the offering, as well as other risk factors and business considerations described in Modular Medical's SEC filings, including its annual report on Form 10-K. Any forward-looking statements in this press release should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent Modular Medical's views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. Modular Medical assumes no obligation to update these forward-looking statements, except as required by law.

Contact:

Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741

SOURCE: Modular Medical, Inc.

View the original press release on ACCESS Newswire

FAQ

How many shares and warrants did Modular Medical (MODD) offer in the March 3, 2026 public offering?

Modular Medical offered 68,098,000 common shares (or pre-funded warrants) and warrants for an additional 68,098,000 shares. According to the company, the combined public offering size and warrant counts were included in the March 3, 2026 filing.

What price did Modular Medical (MODD) set for its March 2026 offering and warrants?

The offering was priced at $0.1762 per share (or pre-funded warrant) and accompanying warrant. According to the company, both the share/pre-funded warrant price and the warrant exercise price are set at $0.1762.

How much gross proceeds will Modular Medical (MODD) raise from the March 3, 2026 offering?

The offering is expected to generate approximately $12.0 million in gross proceeds before fees. According to the company, that figure is before placement agent fees and other offering expenses.

When will the Modular Medical (MODD) public offering close and what conditions apply?

Closing is expected on or about March 4, 2026, subject to customary closing conditions. According to the company, the timing depends on satisfaction of customary closing conditions and finalization of offering logistics.

What are the warrant terms in Modular Medical's (MODD) March 2026 offering?

The warrants are exercisable immediately and expire five years from issuance, with an exercise price of $0.1762 per share. According to the company, the warrants accompany each share or pre-funded warrant sold in the offering.